Compugen (CGEN) Director Mathias Hukkelhoven Receives Awards

What Happened
Mathias Hukkelhoven, a director of Compugen Ltd (CGEN), was granted two awards on 2026-07-29: 7,500 restricted stock units (RSUs) and a 10,000-share option-style award (reported as a derivative). Both awards were reported at $0.00 acquisition price (total reported value $0). These are compensation grants (acquisitions by award), not open-market purchases or sales.

Key Details

• Transaction date: 2026-07-29; Filing date: 2026-07-30 (appears timely).
• Reported acquisition price: $0.00 for both awards; reported total value $0.
• Post-transaction holdings: Not disclosed in the Form 4 filing.
• Footnote F1 (RSU): 7,500 RSUs — 25% vests on Oct 1, 2027; remainder vests in 12 equal quarterly installments thereafter, subject to continued service.
• Footnote F2 (Option): 10,000-share option — vests 25% on Oct 1, 2027; remainder vests in 12 equal quarterly installments thereafter, subject to continued service.
• Transaction code: A = Award/Grant (derivative flagged for the option). No 10b5-1 plan, tax withholding, or late-filing indication noted in the provided info.

Context
RSUs and unexercised option grants are common forms of director compensation and do not involve an immediate outlay or sale of shares. The option award is a derivative grant with a scheduled vesting plan — it was not exercised or sold at the time of the filing. Such awards signal ongoing compensation arrangements rather than an immediate insider buying or selling decision.